Genetic Blockade of NAAA Cell-specifically Regulates Fatty Acid Ethanolamides (FAEs) Metabolism and Inflammatory Responses

Overview

Journal Front Pharmacol

Date 2022 Jan 24

PMID 35069223

Authors

Xiaohua Xie

Yitian Li

Sennan Xu

Pan Zhou

LongHe Yang

Yaping Xu

Yan Qiu

Yungang Yang

Yuhang Li

Affiliations

Soon will be listed here.

Abstract

N-Acylethanolamine acid amidase (NAAA) is a lysosomal enzyme responsible for the hydrolysis of fatty acid ethanolamides (FAEs). However, the role of NAAA in FAEs metabolism and regulation of pain and inflammation remains mostly unknown. Here, we generated NAAA-deficient (NAAA) mice using CRISPR-Cas9 technique, and found that deletion of NAAA increased PEA and AEA levels in bone marrow (BM) and macrophages, and elevated AEA levels in lungs. Unexpectedly, genetic blockade of NAAA caused moderately effective anti-inflammatory effects in lipopolysaccharides (LPS)-induced acute lung injury (ALI), and poor analgesic effects in carrageenan-induced hyperalgesia and sciatic nerve injury (SNI)-induced mechanical allodynia. These data contrasted with acute (single dose) or chronic NAAA inhibition by F96, which produced marked anti-inflammation and analgesia in these models. BM chimera experiments indicated that these phenotypes were associated with the absence of NAAA in non-BM cells, whereas deletion of NAAA in BM or BM-derived cells in rodent models resulted in potent analgesic and anti-inflammatory phenotypes. When combined, current study suggested that genetic blockade of NAAA regulated FAEs metabolism and inflammatory responses in a cell-specifical manner.

Citing Articles

Co-Mn Complex Oxide Nanoparticles as Potential Reactive Oxygen Species Scavenging Agents for Pulmonary Fibrosis Treatment.

Yang W, Yuan H, Sun H, Hu T, Xu Y, Qiu Y Molecules. 2024; 29(21).

PMID: 39519747 PMC: 11547682. DOI: 10.3390/molecules29215106.

Plasma endocannabinoidome and fecal microbiota interplay in people with HIV and subclinical coronary artery disease: Results from the Canadian HIV and Aging Cohort Study.

Mboumba Bouassa R, Giorgini G, Silvestri C, Muller C, Nallabelli N, Alexandrova Y iScience. 2024; 27(8):110456.

PMID: 39156649 PMC: 11326910. DOI: 10.1016/j.isci.2024.110456.

The role of fatty acid metabolism in acute lung injury: a special focus on immunometabolism.

Lu X, Li G, Liu Y, Luo G, Ding S, Zhang T Cell Mol Life Sci. 2024; 81(1):120.

PMID: 38456906 PMC: 10923746. DOI: 10.1007/s00018-024-05131-4.

Imaging and Genetic Tools for the Investigation of the Endocannabinoid System in the CNS.

Kouchaeknejad A, Van Der Walt G, de Donato M, Puighermanal E Int J Mol Sci. 2023; 24(21).

PMID: 37958825 PMC: 10648052. DOI: 10.3390/ijms242115829.

Corylin accelerated wound healing through SIRT1 and PI3K/AKT signaling: a candidate remedy for chronic non-healing wounds.

Xiu Y, Su Y, Gao L, Yuan H, Xu S, Liu Y Front Pharmacol. 2023; 14:1153810.

PMID: 37266148 PMC: 10229780. DOI: 10.3389/fphar.2023.1153810.

References

Tai T, Tsuboi K, Uyama T, Masuda K, Cravatt B, Houchi H . Endogenous molecules stimulating N-acylethanolamine-hydrolyzing acid amidase (NAAA). ACS Chem Neurosci. 2012; 3(5):379-85. PMC: 3382453. DOI: 10.1021/cn300007s. View

Piomelli D, Sasso O . Peripheral gating of pain signals by endogenous lipid mediators. Nat Neurosci. 2014; 17(2):164-74. PMC: 4020413. DOI: 10.1038/nn.3612. View

Singh T, Zhang H, Borek I, Wolf P, Hedrick M, Singh S . Monocyte-derived inflammatory Langerhans cells and dermal dendritic cells mediate psoriasis-like inflammation. Nat Commun. 2016; 7:13581. PMC: 5171657. DOI: 10.1038/ncomms13581. View

Sun M, Lee C, Shin H . Reduced nicotinic receptor function in sympathetic ganglia is responsible for the hypothermia in the acetylcholinesterase knockout mouse. J Physiol. 2006; 578(Pt 3):751-64. PMC: 2151339. DOI: 10.1113/jphysiol.2006.120147. View

Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A . The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol. 2004; 67(1):15-9. DOI: 10.1124/mol.104.006353. View

Bandiera T, Ponzano S, Piomelli D . Advances in the discovery of N-acylethanolamine acid amidase inhibitors. Pharmacol Res. 2014; 86:11-7. PMC: 4117721. DOI: 10.1016/j.phrs.2014.04.011. View

Alhouayek M, Bottemanne P, Subramanian K, Lambert D, Makriyannis A, Cani P . N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis. FASEB J. 2014; 29(2):650-61. PMC: 4763939. DOI: 10.1096/fj.14-255208. View

Fotio Y, Ciccocioppo R, Piomelli D . N-acylethanolamine acid amidase (NAAA) inhibition decreases the motivation for alcohol in Marchigian Sardinian alcohol-preferring rats. Psychopharmacology (Berl). 2020; 238(1):249-258. PMC: 7796956. DOI: 10.1007/s00213-020-05678-7. View

Fotio Y, Jung K, Palese F, Obenaus A, Mabou Tagne A, Lin L . NAAA-regulated lipid signaling governs the transition from acute to chronic pain. Sci Adv. 2021; 7(43):eabi8834. PMC: 8535814. DOI: 10.1126/sciadv.abi8834. View

10.

Ran F, Hsu P, Wright J, Agarwala V, Scott D, Zhang F . Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013; 8(11):2281-2308. PMC: 3969860. DOI: 10.1038/nprot.2013.143. View

11.

Li Y, Zhou P, Chen H, Chen Q, Kuang X, Lu C . Inflammation-restricted anti-inflammatory activities of a N-acylethanolamine acid amidase (NAAA) inhibitor F215. Pharmacol Res. 2018; 132:7-14. DOI: 10.1016/j.phrs.2018.03.011. View

12.

Solorzano C, Zhu C, Battista N, Astarita G, Lodola A, Rivara S . Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation. Proc Natl Acad Sci U S A. 2009; 106(49):20966-71. PMC: 2791595. DOI: 10.1073/pnas.0907417106. View

13.

Zygmunt P, Petersson J, Andersson D, Chuang H, Sorgard M, Di Marzo V . Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 1999; 400(6743):452-7. DOI: 10.1038/22761. View

14.

Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodriguez de Fonseca F . Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature. 2003; 425(6953):90-3. DOI: 10.1038/nature01921. View

15.

Ahn K, Smith S, Liimatta M, Beidler D, Sadagopan N, Dudley D . Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain. J Pharmacol Exp Ther. 2011; 338(1):114-24. PMC: 3126636. DOI: 10.1124/jpet.111.180257. View

16.

Ueda N, Tsuboi K, Uyama T . N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA). Prog Lipid Res. 2010; 49(4):299-315. DOI: 10.1016/j.plipres.2010.02.003. View

17.

Bonezzi F, Sasso O, Pontis S, Realini N, Romeo E, Ponzano S . An Important Role for N-Acylethanolamine Acid Amidase in the Complete Freund's Adjuvant Rat Model of Arthritis. J Pharmacol Exp Ther. 2016; 356(3):656-63. DOI: 10.1124/jpet.115.230516. View

18.

Alhouayek M, Bottemanne P, Makriyannis A, Muccioli G . N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation. Biochim Biophys Acta Mol Cell Biol Lipids. 2017; 1862(5):474-484. DOI: 10.1016/j.bbalip.2017.01.001. View

19.

Carnevali L, Rivara S, Nalivaiko E, Thayer J, Vacondio F, Mor M . Pharmacological inhibition of FAAH activity in rodents: A promising pharmacological approach for psychological-cardiac comorbidity?. Neurosci Biobehav Rev. 2016; 74(Pt B):444-452. DOI: 10.1016/j.neubiorev.2016.04.013. View

20.

McKinney M, Cravatt B . Structure and function of fatty acid amide hydrolase. Annu Rev Biochem. 2005; 74:411-32. DOI: 10.1146/annurev.biochem.74.082803.133450. View